Equity
Convertible Preferred Stock Authorized Shares
Gilead Sciences Convertible Preferred Stock Authorized Shares remained flat by 0.0% to 5M in Q3 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 5M to 5M. Over 4 years (FY 2020 to FY 2024), Convertible Preferred Stock Authorized Shares shows relatively stable performance with a 0.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase in authorized shares provides greater capital-raising flexibility but may signal potential future dilution for common shareholders.
Detailed definition
This represents the maximum number of convertible preferred shares that the company is legally permitted to issue under...
Peer comparison
Standard corporate governance metric; levels are usually set high to provide long-term flexibility.
Metric ID:
convertible_preferred_stock_authorized_sharesHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Range5M – 5M
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak17+ quarters growth
Convertible Preferred Stock Authorized Shares at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's convertible preferred stock authorized shares?
- Gilead Sciences (GILD) reported convertible preferred stock authorized shares of 5M in Q3 2025.
- How has Gilead Sciences's convertible preferred stock authorized shares changed year-over-year?
- Gilead Sciences's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 5M to 5M.
- What is the long-term trend for Gilead Sciences's convertible preferred stock authorized shares?
- Over 4 years (2020 to 2024), Gilead Sciences's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 5M to 5M.
- What does convertible preferred stock authorized shares mean?
- The maximum number of convertible preferred shares the company is allowed to issue.